Sökning: WFRF:(Pfeffer K.) >
Red cell distributi...
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank
-
Felker, G. M. (författare)
-
Allen, L. A. (författare)
-
Pocock, S. J. (författare)
-
visa fler...
-
Shaw, L. K. (författare)
-
McMurray, J. J. (författare)
-
Pfeffer, M. A. (författare)
-
- Swedberg, Karl, 1944 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för akut och kardiovaskulär medicin,Institute of Medicine, Department of Emergeny and Cardiovascular Medicine
-
Wang, D. (författare)
-
Yusuf, S. (författare)
-
Michelson, E. L. (författare)
-
Granger, C. B. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2007
- 2007
- Engelska.
-
Ingår i: J Am Coll Cardiol. - 1558-3597. ; 50:1, s. 40-7
- Relaterad länk:
-
https://gup.ub.gu.se...
Abstract
Ämnesord
Stäng
- OBJECTIVES: The goal of this study was to identify potentially novel laboratory markers of risk in chronic heart failure patients. BACKGROUND: Although a variety of prognostic markers have been described in heart failure, a systematic assessment of routine laboratory values has not been reported. METHODS: All 2,679 symptomatic chronic heart failure patients from the North American CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) program had a wide range of laboratory measures performed at a core facility, enabling us to assess the relationship between routine blood tests and outcomes using a Cox proportional hazards model. We then replicated our findings in a cohort of 2,140 heart failure patients from the Duke Databank. RESULTS: Among 36 laboratory values considered in the CHARM program, higher red cell distribution width (RDW) showed the greatest association with morbidity and mortality (adjusted hazard ratio 1.17 per 1-SD increase, p < 0.001). Higher RDW was among the most powerful overall predictors, with only age and cardiomegaly showing a better independent association with outcome. This finding was replicated in the Duke Databank, in which higher RDW was strongly associated with all-cause mortality (adjusted hazard ratio 1.29 per 1 SD, p < 0.001), second only to age as a predictor of outcome. CONCLUSIONS: In 2 large contemporary heart failure populations, RDW was found to be a very strong independent predictor of morbidity and mortality. Understanding how and why this marker is associated with outcome may provide novel insights into heart failure pathophysiology.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Aged
- Benzimidazoles/*therapeutic use
- Biological Markers/blood
- *Cause of Death
- Cohort Studies
- Databases as Topic
- Disease Progression
- Erythrocytes/*cytology
- Female
- Heart Failure/diagnosis/*drug therapy/*mortality
- Humans
- Male
- Middle Aged
- Multivariate Analysis
- Probability
- Prognosis
- Proportional Hazards Models
- Randomized Controlled Trials as Topic
- Risk Assessment
- Sensitivity and Specificity
- Severity of Illness Index
- Survival Analysis
- Tetrazoles/*therapeutic use
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Felker, G. M.
-
Allen, L. A.
-
Pocock, S. J.
-
Shaw, L. K.
-
McMurray, J. J.
-
Pfeffer, M. A.
-
visa fler...
-
Swedberg, Karl, ...
-
Wang, D.
-
Yusuf, S.
-
Michelson, E. L.
-
Granger, C. B.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
J Am Coll Cardio ...
- Av lärosätet
-
Göteborgs universitet